Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus

• Hoofdauteurs: Mohsin Kazi (Auteur), Abdulmohsen Alqahtani (Auteur), Ajaz Ahmad (Auteur), Omar M. Noman (Auteur), Mohammed S. Aldughaim (Auteur), Ali S. Alqahtani (Auteur), Fars K. Alanazi (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Control of hyperglycemia and prevention of glucose reabsorption (glucotoxicity) are important objectives in the management of type 2 diabetes. This study deals with an oral combined dosage form design for two anti-diabetic drugs, sitagliptin and dapagliflozin using self-nanoemulsifying drug delivery...